SCHEMBL4339249

SCHEMBL4339249

CCOc1ccc(NC(=O)OCc2cccc(CC(OC(C)C)C(=O)O)c2)cc1OC

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.46
FPR2 P25090 1/20 0.46
MEN1 O00255 3/20 0.45
KMT2A Q03164 3/20 0.45
MCHR1 Q99705 3/20 0.42
LMNA P02545 1/20 0.41
TSHR P16473 1/20 0.41
GAA P10253 2/20 0.40
MAPT P10636 2/20 0.40
KDM4E B2RXH2 1/20 0.40
POLB P06746 1/20 0.40
MGLL Q99685 1/20 0.40
KCNK3 O14649 1/20 0.39
KCNK9 Q9NPC2 1/20 0.39
CTSV O60911 1/20 0.39
CTSL P07711 1/20 0.39
CALM1 P0DP23 1/20 0.39
MMP1 P03956 1/20 0.39
MMP2 P08253 1/20 0.39
MMP3 P08254 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4334222 0.87 SMN1; SMN2 (0.48) SMN1; SMN2FPR2MEN1KMT2ALMNA
SCHEMBL4345880 0.87 MGLL (0.41) SMN1; SMN2MEN1KMT2ALMNAMAPT
SCHEMBL4328008 0.86 TP53 (0.47) SMN1; SMN2MEN1KMT2ALMNAMAPT
SCHEMBL4337066 0.85 SMN1; SMN2 (0.56) SMN1; SMN2FPR2MEN1KMT2ALMNA
SCHEMBL4328737 0.84 FPR2 (0.48) SMN1; SMN2FPR2MEN1KMT2ALMNA
SCHEMBL4328989 0.83 MGLL (0.43) SMN1; SMN2FPR2KMT2ALMNAMAPT
SCHEMBL4341708 0.83 ALDH1A1 (0.44) SMN1; SMN2FPR2LMNAGAAMAPT
SCHEMBL4328906 0.82 MGLL (0.52) MEN1KMT2ALMNAMAPTPOLB
SCHEMBL4339291 0.81 MEN1 (0.50) SMN1; SMN2MEN1KMT2ALMNAMAPT
SCHEMBL13810563 0.81 MTNR1B (0.46) SMN1; SMN2MEN1KMT2ALMNATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7544835-B2 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-09 US disclosed
US-20040102634-A1 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-05-27 US disclosed
EP-1380562-A1 CARBOXYLIC ACID DERIVATIVE AND SALT THEREOF Eisai Co., Ltd. (JP) 2004-01-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040102634-A1 Carboxylic acid derivative and salt thereof GPR119, IRS1, SLC5A1 SMN1; SMN2 3054/4885FPR2 632/4885MEN1 4091/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.